From: Artichoke extracts in cancer therapy: do the extraction conditions affect the anticancer activity?
Extraction method | Yield | Cancer type | Viability % | Reference |
---|---|---|---|---|
Aqueous | Not included | Breast cancer (T-47D) | 4–5 times decrease | [22] |
Breast cancer (ZR-75-1) | 6–8.5 times decreased | |||
50% ethanol | Scopoletin | Breast cancer (T-47D) | 8–9 times decrease | [22] |
Apigenin | ZR-75-1 | 10–13 times decrease | ||
Diosmetin | ||||
Isohoifolin | ||||
Salvigenin | ||||
Naringin dihydrochalcone | ||||
Ursolic acid | ||||
Stearidonic acid methyl ester | ||||
Stearidonic ethyl ester | ||||
Methanol | Chlorogenic acid: 725±70 mg/L | Prostate (DU 145) | 50% | |
3,5-Dicaffeoylquinic acid (DCQA): 738 ± 58 mg/L | Melanoma (M14) | 50% | ||
1,5-DCQA: 632 ± 48 mg/L | Breast (MDA-MB231) | 17% | ||
Ovary (HEY) | 30% | |||
Lung (A549) | 32% | |||
Brain (U-373 MG) | 17% | |||
Bone (Saos-2) | 20% | |||
Leukaemia (K-562) | 17% | |||
Breast (BT549, T47D and MCF-7) | 20% | |||
Ethanol | Heart total phenolic compounds (TPC): 9.06 ± 0.06 mg/g | Liver (HePG2) | Heart-free phenolic extract shows 36.7% at 100 ppm | [33] |
Heart total flavonoid compounds (TFC): 5.91 ± 0.12 mg/g | Heart-bound phenolic extract shows 27.2% at 100 ppm | |||
Bracts (TPC): 14.16 ± 0.08 mg/g | Bract-free phenolic extract shows 75.3% at 100 ppm | |||
Bracts (TFC): 9.85 ± 0.12 mg/g | Bract bound phenolic extract shows 14% at 100 ppm | |||
Methanol | Mono-caffeoylquinic acid 1: 17 ± 2 mg/L | Liver (HePG2) | 20% | [32] |
Mono-caffeoylquinic acid 2: 13 ± 1 mg/L | ||||
Chlorogenic acid: 730 ± 78 mg/L | ||||
Mono-caffeoylquinic acid 3: 17 ± 2 mg/L | ||||
Di-caffeoylquinic acid 1: 4 ± 0.5 mg/L | ||||
Di-caffeoylquinic acid 2: 8 ± 1 mg/L | ||||
Di-caffeoylquinic acid 3: 16 ± 2 mg/L | ||||
Di-caffeoylquinic acid 4: 745 ± 62 mg/L | ||||
Di-caffeoylquinic acid 5: 645 ± 54 mg/L | ||||
Di-caffeoylquinic acid 6: 35 ± 3 mg/L | ||||
Luteolin-glycoside: 23 ± 5 mg/L | ||||
Apigenin-glycoside: 25 ± 5 mg/L | ||||
Ethanol | 3.44% of total hydroxycinnamic acids expressed as chlorogenic acid and 0.4% of total flavonoid content calculated as luteolin | Leukaemia (L1210 and HL-60 cells) | < 20% of cellular growth | [40] |
Ethanol | Caffeoylquinic acid derivatives: 10.33% of 34.251% of polyphenols | Pleural mesothelioma (MSTO-211H) | Not included | [42] |
Saccharides (%): 24.69 | ||||
Ethanol | Total phenolics: 101.07 ± 0.63 mg/g | Not included | Not included | [62] |
3-CQA: 30.42 ± 0.37 mg/g | ||||
Caffeic acid 2.12 ± 0.09 mg/g | ||||
3,5-DCQA: 1.47 ± 0.15 mg/g | ||||
1,5-DCQA: 8.27 ± 0.54 mg/g | ||||
4,5-DCQA: 2.17 ± 0.21 mg/g | ||||
3,5-DCQAME: 0.53 ± 0.05 mg/g | ||||
Re-extracting crude extract with petroleum ether | Total phenolics: 31.89 ± 0.42 mg/g | Not included | Not included | [62] |
3-CQA: 2.11 ± 0.09 mg/g | ||||
Caffeic acid: 1.56 ± 0.03 mg/g | ||||
3,5-DCQA: 0.42 ± 0.03 mg/g | ||||
1,5-DCQA: 1.59 ± 0.09 mg/g | ||||
4,5-DCQA: 0.41 ± 0.09 mg/g | ||||
3,5-DCQAME: ND | ||||
Re-extracting crude extract with ethyl acetate | Total phenolics: 266.69 ± 2.51 mg/g | Not included | Not included | [62] |
3-CQA: 9.84 ± 0.61 mg/g | ||||
Caffeic acid: 13.83 ± 0.44 mg/g | ||||
3,5-DCQA: 27.18 ± 1.59 mg/g | ||||
1,5-DCQA: 104.51 ± 2.86 mg/g | ||||
4,5-DCQA: 19.29 ± 0.44 mg/g | ||||
3,5-DCQAME: 20.67 ± 0.83 mg/g | ||||
Re-extracting crude extract with n-butanol | Total phenolics: 135.72 ± 1.07 mg/g | Not included | Not included | [62] |
3-CQA: 74.58 ± 1.05 mg/g | ||||
Caffeic acid: 3.36 ± 0.33 mg/g | ||||
3,5-DCQA: 2.21 ± 0.19 mg/g | ||||
1,5-DCQA: 15.87 ± 1.09 mg/g | ||||
4,5-DCQA: 3.41 ± 0.21 mg/g | ||||
3,5-DCQAME: 0.81 ± 0.12 mg/g | ||||
Re-extracting crude extract with water | Total phenolics: 52.45 ± 1.44 mg/g | Not included | Not included | [62] |
3-CQA: 20.64 ± 0.76 mg/g | ||||
1,5-DCQA: 7.94 ± 0.39 mg/g | ||||
Caffeic acid; 3,5-DCQA; 4,5-DCQA and DCQAME: ND |